Helicos Seeks Approval to Sell Assets, IP to Employee to Form New Company | GenomeWeb

NEW YORK (GenomeWeb News) – Helicos BioSciences, currently in Chapter 11 bankruptcy protection, is seeking approval from bankruptcy court to sell its assets to an employee who plans to form a new company using Helicos' technology, the company said in a court filing last week.

The US Bankruptcy Court for the District of Massachusetts Eastern Division will hold a hearing on Helicos' motion for approval of the proposed deal on Thursday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.